Evidence map›Paper›PMID 32143505›Full record

ArticlePharmaceutics2020

Hierarchical Porous Carbon-PLLA and PLGA Hybrid Nanoparticles for Intranasal Delivery of Galantamine for Alzheimer's Disease Therapy.

Stavroula G Nanaki, Konstantinos Spyrou, Chryssa Bekiari, Pelagia Veneti, Turki N Baroud, Niki Karouta, Ioannis Grivas, Georgios C Papadopoulos, Dimitrios Gournis, Dimitrios N Bikiaris

Abstract read
In one paragraph

Article in Pharmaceutics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Review
  15. Review
  16. Recent progress of nanomedicine in the treatment of Alzheimer's disease.Frontiers in cell and developmental biology · 2023
    Review
  17. Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Stavroula G NanakiDepartment of Chemistry, Laboratory of Polymers and Colors Chemistry and Technology, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece.
Konstantinos SpyrouDepartment of Materials Science and Engineering, University of Ioannina, 45110 Ioannina, Greece.
Chryssa BekiariLaboratoryof Anatomy, Histology and Embryology, School of Veterinary Medicine, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece.
Pelagia VenetiDepartment of Chemistry, Laboratory of Polymers and Colors Chemistry and Technology, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece.
Turki N BaroudDepartment of Mechanical Engineering, King Fahd University of Petroleum & Minerals, Dhahran 31261, Saudi Arabia.ORCID 0000-0001-6430-9128
Niki KaroutaDepartment of Materials Science and Engineering, University of Ioannina, 45110 Ioannina, Greece.
Ioannis GrivasLaboratoryof Anatomy, Histology and Embryology, School of Veterinary Medicine, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece.
Georgios C PapadopoulosLaboratoryof Anatomy, Histology and Embryology, School of Veterinary Medicine, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece.
Dimitrios GournisDepartment of Materials Science and Engineering, University of Ioannina, 45110 Ioannina, Greece.ORCID 0000-0003-4256-8190
Dimitrios N BikiarisDepartment of Chemistry, Laboratory of Polymers and Colors Chemistry and Technology, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece.ORCID 0000-0001-8458-4952

Funding

This project has received funding from the Hellenic Foundation for Research and Innovation (HFRI) and the General Secretariat for Research and Technology (GSRT), under grant agreement No [1914]. 1914
6 · The paper itself

Abstract

In the present study, poly(l-lactic acid) (PLLA) and poly(lactide-

Indexed as

Alzheimer’sdrug deliverygalantaminehierarchical porous carbonintranasal deliverynanoencapsulationpoly(lactide-co-glycolide)poly(l-lactic acid)

Identifiers

PMID32143505
PMCPMC7150929

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.